Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Jordan R. Barrett, Sandra Belij‐Rammerstorfer, Christina Dold, Katie Ewer, Pedro M. Folegatti, Ciarán Gilbride, Rachel Halkerston, Jennifer Hill, Daniel Jenkin, Lisa Stockdale, Marije K. Verheul, Parvinder K. Aley, Brian Angus, Duncan Bellamy, Eleanor Berrie, Sagida Bibi, Mustapha Bittaye, Miles W. Carroll, Breeze E. Cavell, Elizabeth Clutterbuck, Nick J. Edwards, Amy Flaxman, Michelle Fuskova, Andrew Gorringe, Bassam Hallis, Simon Kerridge, Alison M. Lawrie, Aline Linder, Xinxue Liu, Meera Madhavan, Rebecca Makinson, Jack Mellors, Angela M. Minassian, Maria Moore, Yama F Mujadidi, Emma Plested, Ian Poulton, Maheshi Ramasamy, Hannah Robinson, Christine S. Rollier, Rinn Song, Matthew D. Snape, Richard Tarrant, Stephen Taylor, Kelly Thomas, Merryn Voysey, Marion Watson, Daniel Wright, Alexander D. Douglas, Catherine Green, Adrian V. S. Hill, Teresa Lambe, Sarah C. Gilbert, Andrew J. Pollard, the Oxford COVID Vaccine Trial Group, Jeremy Aboagye, Jennifer Alderson, Aabidah Ali, Elizabeth Allen, Lauren Allen, Rachel Anslow, Carolina V. Arancibia-Cárcamo, Edward H. Arbe-Barnes, Megan Baker, Philip Baker, Natalie Baker, Ioana Baleanu, Eleanor Barnes, Louise Bates, Alexander Batten, Kirsten Beadon, Rebecca Beckley, Amy Beveridge, Kevin R. Bewley, Else M. Bijker, Luke Blackwell, Caitlin L. Blundell, Emma Bolam, Elena Boland, Nicola Borthwick, Amy Boyd, Tanja Brenner, Philip N. Brown, Charlie Brown-O’Sullivan, Emily Brunt, Jamie Burbage, Karen R. Buttigieg, Nicholas Byard, Ingrid Cabrera Puig, Susana Camara, Michelangelo Cao, Federica Cappuccini, Melanie Carr, Miles W. Carroll, Jim Chadwick, Irina Chelysheva, Jee-Sun Cho, Liliana Cifuentes, Elizabeth Clark, Rachel Colin-Jones